O presente trabalho consiste na síntese, caracterização e estudos de atividade tripanocida de doze compostos, sendo oito tiossemicarbazonas (TSCs) e quatro ditiocarbazatos (DTCs), contendo anel pirazolínico em suas estruturas, assim como no estudo da formação de complexos de um DTC com GaIII. As TSCs e os DTCs foram obtidos em reações de condensação envolvendo uma β-dicetona e uma tiossemicarbazida ou ditiocarbazato, respectivamente. A partir de 1-fenil-1,3-butanodiona (benzoilacetona) e 4-R-tiossemicarbazida, foram obtidas as TSCs de nome 5-hidroxi-3-metil-5-fenil-pirazolina-1-(4-R-tiossemicarbazona), identificados como H2bt, H2bmt, H2bet e H2bpt, com R = H, Me, Et e Ph, respectivamente. Mudando a β-dicetona para 4,4,4-trifluoro-1-fenil-1,3-butanodiona, foram obtidas as TSCs de nome 5-hidroxi-3-fenil-5-trifluorometil-pirazolina-1-(4-R-tiossemicarbazona), identificados como H2ft, H2fmt, H2fet e H2fpt, com R = H, Me, Et e Ph, respectivamente. De modo similar, os DTCs de nome 5-hidroxi-3-metil-5-fenil-pirazolina-1-(S-p-R-benzilditiocarbazato), H2bdtc e H2mbdtc, para R = H e OMe, respectivamente, foram obtidos a partir de benzoilacetona e S-p-R-benzilditiocarbazato, enquanto que os DTCs de nome 5-hidroxi-3-fenil-5-trifluorometil-pirazolina-1-(S-p-R-benzilditiocarbazato), H2fdtc e H2mfdtc, para R = H e OMe, respectivamente, formaram-se quando a 4,4,4-trifluoro-1-fenil-1,3-butanodiona foi a β-dicetona utilizada. Os compostos foram caracterizados por diversas técnicas, que incluíram análise elementar, espectroscopia na região do infravermelho (IV), espectrometria de massas, ressonância magnética nuclear de hidrogênio e flúor (RMN1H e 19F) e difração de raios X em monocristal. As TSCs e os DTCs foram avaliados quanto a suas atividades anti-T. cruzi e citotoxicidade frente a células de macrófagos J774, sendo possível avaliar as influências dos grupos periféricos substituintes. Nestes estudos, dois novos compostos, além do H2bdtc, cuja atividade é conhecida, se mostraram promissores, H2bt e H2bmt, apresentando valores de atividade tripanocida CC50try = 9,91 e 6,85 µM, respectivamente, para a cepa Y na forma tripomastigota do T. cruzi. Ambos foram superiores ao benzonidazol, utilizado como referência (CC50try = 10,6 µM). Os compostos também se mostraram seletivos, com CC50 > 100 µM para células de macrófago J774. Estudos de complexação com GaIII utilizando H2bdtc como agente complexante levaram a dois novos complexos, variando-se as condições reacionais, sendo um mononuclear, [Ga(bdtc)(Hbdtc)].CH3OH, e um dinuclear, [Ga2(bdtc)2(µOCH3)2].CH2Cl2, os quais foram caracterizados, tanto em solução quanto no estado sólido, tendo tido suas estruturas determinadas por difração de raios X em monocristal. Ambos apresentam centros de GaIII pentacoordenados, com grau de distorção diferenciado, entre uma geometria de coordenação bipiramidal trigonal e piramidal de base quadrada. Quando dianiônico, o bdtc2- coordenou-se O,N,S-tridentado, diferentemente da forma S,N-bidentada observa para o DTC, quando coordenado monoaniônico, como bdtc1-. / The present work describes the synthesis, structural characterization and trypanocidal activity studies of twelve compounds, eight thiosemicarbazones (TSCs) and four dithiocarbazates (DTCs) containing pyrazoline ring in their structures, as well as in the study of complex formation of a DTC with GaIII. The TSCs and DTCs were obtained from condensation reactions involving a & beta;-diketone and a dithiocarbazate or thiosemicarbazide, respectively. From 1-phenyl-1,3-butanedione (benzoylacetone) and 4-R-thiosemicarbazide were obtained TSCs the name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2bt, H2bmt, H2bet and H2bpt, R = H, Me, Et, Ph, respectively. Changing the & beta;-diketone for 4,4,4-trifluoro-1-phenyl-1,3-butanedione result in TSCs the name 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2ft, H2fmt, H2fet and H2fpt, R = H, Me, Et, Ph, respectively. Similarly, the DTCs with name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2bdtc and H2mbdtc to R = H and OMe, respectively, were obtained from benzoylacetone and S-p-R-benzyldithiocarbazate, while DTCs 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2fdtc and H2mfdtc to R = H and OMe, respectively, are formed with 4,4,4-trifluoro-1-phenyl-1,3-butanedione. The compounds were characterized by various techniques such as elemental analysis, infrared spectroscopy (IR), mass spectrometry, nuclear magnetic resonance of hydrogen and fluorine (1H and 19F NMR) and single crystals X-ray diffraction. The TSCs and DTCs were evaluated for their anti-T. cruzi activity and cytotoxicity against macrophage cells, making it possible to evaluate the effects of substituent peripheral groups. In these studies, other two new compounds than H2bdtc whose activity is known, were considered promising, H2bt and H2bmt, having superior activity, CC50try values 9.91 and 6.85 µM, respectively, compared with benznidazole used as reference (CC50try = 10.6 µM). The compounds also show selective with CC50> 100 µM for J774 macrophage cells. In the complexation studies with GaIII using H2bdtc it is possible to obtain two new complex, varying the reaction conditions, being a mononuclear, [Ga(bdtc)(Hbdtc)]·CH3OH, and other dinuclear [Ga2(bdtc)2(µ OCH3)2].CH2Cl2, which were characterized both in solution and in solid state, having their structures determined by single crystals X-ray diffraction. Both having GaIII pentacoordenate, with distortion of coordination geometry between trigonal bipyramidal and square pyramidal. When the ligand bdtc2- coordinated dianionic the form is O,N,S-tridentate, unlike the form S,N-bidentate was observed for the DTC when coordinated monoanionic as bdtc1-.The present work describes the synthesis, structural characterization and trypanocidal activity studies of twelve compounds, eight thiosemicarbazones (TSCs) and four dithiocarbazates (DTCs) containing pyrazoline ring in their structures, as well as in the study of complex formation of a DTC with GaIII. The TSCs and DTCs were obtained from condensation reactions involving a ?-diketone and a dithiocarbazate or thiosemicarbazide, respectively. From 1-phenyl-1,3-butanedione (benzoylacetone) and 4-R-thiosemicarbazide were obtained TSCs the name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2bt, H2bmt, H2bet and H2bpt, R = H, Me, Et, Ph, respectively. Changing the ?-diketone for 4,4,4-trifluoro-1-phenyl-1,3-butanedione result in TSCs the name 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2ft, H2fmt, H2fet and H2fpt, R = H, Me, Et, Ph, respectively. Similarly, the DTCs with name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2bdtc and H2mbdtc to R = H and OMe, respectively, were obtained from benzoylacetone and S-p-R-benzyldithiocarbazate, while DTCs 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2fdtc and H2mfdtc to R = H and OMe, respectively, are formed with 4,4,4-trifluoro-1-phenyl-1,3-butanedione. The compounds were characterized by various techniques such as elemental analysis, infrared spectroscopy (IR), mass spectrometry, nuclear magnetic resonance of hydrogen and fluorine (1H and 19F NMR) and single crystals X-ray diffraction. The TSCs and DTCs were evaluated for their anti-T. cruzi activity and cytotoxicity against macrophage cells, making it possible to evaluate the effects of substituent peripheral groups. In these studies, other two new compounds than H2bdtc whose activity is known, were considered promising, H2bt and H2bmt, having superior activity, CC50try values 9.91 and 6.85 µM, respectively, compared with benznidazole used as reference (CC50try = 10.6 µM). The compounds also show selective with CC50> 100 µM for J774 macrophage cells. In the complexation studies with GaIII using H2bdtc it is possible to obtain two new complex, varying the reaction conditions, being a mononuclear, [Ga(bdtc)(Hbdtc)]·CH3OH, and other dinuclear [Ga2(bdtc)2(?-OCH3)2]·CH2Cl2, which were characterized both in solution and in solid state, having their structures determined by single crystals X-ray diffraction. Both having GaIII pentacoordenate, with distortion of coordination geometry between trigonal bipyramidal and square pyramidal. When the ligand bdtc2- coordinated dianionic the form is O,N,S-tridentate, unlike the form S,N-bidentate was observed for the DTC when coordinated monoanionic as bdtc1-.

O presente trabalho consiste na síntese, caracterização e estudos de atividade tripanocida de doze compostos, sendo oito tiossemicarbazonas (TSCs) e quatro ditiocarbazatos (DTCs), contendo anel pirazolínico em suas estruturas, assim como no estudo da formação de complexos de um DTC com GaIII. As TSCs e os DTCs foram obtidos em reações de condensação envolvendo uma β-dicetona e uma tiossemicarbazida ou ditiocarbazato, respectivamente. A partir de 1-fenil-1,3-butanodiona (benzoilacetona) e 4-R-tiossemicarbazida, foram obtidas as TSCs de nome 5-hidroxi-3-metil-5-fenil-pirazolina-1-(4-R-tiossemicarbazona), identificados como H2bt, H2bmt, H2bet e H2bpt, com R = H, Me, Et e Ph, respectivamente. Mudando a β-dicetona para 4,4,4-trifluoro-1-fenil-1,3-butanodiona, foram obtidas as TSCs de nome 5-hidroxi-3-fenil-5-trifluorometil-pirazolina-1-(4-R-tiossemicarbazona), identificados como H2ft, H2fmt, H2fet e H2fpt, com R = H, Me, Et e Ph, respectivamente. De modo similar, os DTCs de nome 5-hidroxi-3-metil-5-fenil-pirazolina-1-(S-p-R-benzilditiocarbazato), H2bdtc e H2mbdtc, para R = H e OMe, respectivamente, foram obtidos a partir de benzoilacetona e S-p-R-benzilditiocarbazato, enquanto que os DTCs de nome 5-hidroxi-3-fenil-5-trifluorometil-pirazolina-1-(S-p-R-benzilditiocarbazato), H2fdtc e H2mfdtc, para R = H e OMe, respectivamente, formaram-se quando a 4,4,4-trifluoro-1-fenil-1,3-butanodiona foi a β-dicetona utilizada. Os compostos foram caracterizados por diversas técnicas, que incluíram análise elementar, espectroscopia na região do infravermelho (IV), espectrometria de massas, ressonância magnética nuclear de hidrogênio e flúor (RMN1H e 19F) e difração de raios X em monocristal. As TSCs e os DTCs foram avaliados quanto a suas atividades anti-T. cruzi e citotoxicidade frente a células de macrófagos J774, sendo possível avaliar as influências dos grupos periféricos substituintes. Nestes estudos, dois novos compostos, além do H2bdtc, cuja atividade é conhecida, se mostraram promissores, H2bt e H2bmt, apresentando valores de atividade tripanocida CC50try = 9,91 e 6,85 µM, respectivamente, para a cepa Y na forma tripomastigota do T. cruzi. Ambos foram superiores ao benzonidazol, utilizado como referência (CC50try = 10,6 µM). Os compostos também se mostraram seletivos, com CC50 > 100 µM para células de macrófago J774. Estudos de complexação com GaIII utilizando H2bdtc como agente complexante levaram a dois novos complexos, variando-se as condições reacionais, sendo um mononuclear, [Ga(bdtc)(Hbdtc)].CH3OH, e um dinuclear, [Ga2(bdtc)2(µOCH3)2].CH2Cl2, os quais foram caracterizados, tanto em solução quanto no estado sólido, tendo tido suas estruturas determinadas por difração de raios X em monocristal. Ambos apresentam centros de GaIII pentacoordenados, com grau de distorção diferenciado, entre uma geometria de coordenação bipiramidal trigonal e piramidal de base quadrada. Quando dianiônico, o bdtc2- coordenou-se O,N,S-tridentado, diferentemente da forma S,N-bidentada observa para o DTC, quando coordenado monoaniônico, como bdtc1-. / The present work describes the synthesis, structural characterization and trypanocidal activity studies of twelve compounds, eight thiosemicarbazones (TSCs) and four dithiocarbazates (DTCs) containing pyrazoline ring in their structures, as well as in the study of complex formation of a DTC with GaIII. The TSCs and DTCs were obtained from condensation reactions involving a & beta;-diketone and a dithiocarbazate or thiosemicarbazide, respectively. From 1-phenyl-1,3-butanedione (benzoylacetone) and 4-R-thiosemicarbazide were obtained TSCs the name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2bt, H2bmt, H2bet and H2bpt, R = H, Me, Et, Ph, respectively. Changing the & beta;-diketone for 4,4,4-trifluoro-1-phenyl-1,3-butanedione result in TSCs the name 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2ft, H2fmt, H2fet and H2fpt, R = H, Me, Et, Ph, respectively. Similarly, the DTCs with name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2bdtc and H2mbdtc to R = H and OMe, respectively, were obtained from benzoylacetone and S-p-R-benzyldithiocarbazate, while DTCs 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2fdtc and H2mfdtc to R = H and OMe, respectively, are formed with 4,4,4-trifluoro-1-phenyl-1,3-butanedione. The compounds were characterized by various techniques such as elemental analysis, infrared spectroscopy (IR), mass spectrometry, nuclear magnetic resonance of hydrogen and fluorine (1H and 19F NMR) and single crystals X-ray diffraction. The TSCs and DTCs were evaluated for their anti-T. cruzi activity and cytotoxicity against macrophage cells, making it possible to evaluate the effects of substituent peripheral groups. In these studies, other two new compounds than H2bdtc whose activity is known, were considered promising, H2bt and H2bmt, having superior activity, CC50try values 9.91 and 6.85 µM, respectively, compared with benznidazole used as reference (CC50try = 10.6 µM). The compounds also show selective with CC50> 100 µM for J774 macrophage cells. In the complexation studies with GaIII using H2bdtc it is possible to obtain two new complex, varying the reaction conditions, being a mononuclear, [Ga(bdtc)(Hbdtc)]·CH3OH, and other dinuclear [Ga2(bdtc)2(µ OCH3)2].CH2Cl2, which were characterized both in solution and in solid state, having their structures determined by single crystals X-ray diffraction. Both having GaIII pentacoordenate, with distortion of coordination geometry between trigonal bipyramidal and square pyramidal. When the ligand bdtc2- coordinated dianionic the form is O,N,S-tridentate, unlike the form S,N-bidentate was observed for the DTC when coordinated monoanionic as bdtc1-.The present work describes the synthesis, structural characterization and trypanocidal activity studies of twelve compounds, eight thiosemicarbazones (TSCs) and four dithiocarbazates (DTCs) containing pyrazoline ring in their structures, as well as in the study of complex formation of a DTC with GaIII. The TSCs and DTCs were obtained from condensation reactions involving a ?-diketone and a dithiocarbazate or thiosemicarbazide, respectively. From 1-phenyl-1,3-butanedione (benzoylacetone) and 4-R-thiosemicarbazide were obtained TSCs the name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2bt, H2bmt, H2bet and H2bpt, R = H, Me, Et, Ph, respectively. Changing the ?-diketone for 4,4,4-trifluoro-1-phenyl-1,3-butanedione result in TSCs the name 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(4-R-thiosemicarbazone), identified as H2ft, H2fmt, H2fet and H2fpt, R = H, Me, Et, Ph, respectively. Similarly, the DTCs with name 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2bdtc and H2mbdtc to R = H and OMe, respectively, were obtained from benzoylacetone and S-p-R-benzyldithiocarbazate, while DTCs 5-hydroxy-3-phenyl-5-trifluoromethyl-pyrazoline-1-(S-p-R-benzyldithiocarbazate), H2fdtc and H2mfdtc to R = H and OMe, respectively, are formed with 4,4,4-trifluoro-1-phenyl-1,3-butanedione. The compounds were characterized by various techniques such as elemental analysis, infrared spectroscopy (IR), mass spectrometry, nuclear magnetic resonance of hydrogen and fluorine (1H and 19F NMR) and single crystals X-ray diffraction. The TSCs and DTCs were evaluated for their anti-T. cruzi activity and cytotoxicity against macrophage cells, making it possible to evaluate the effects of substituent peripheral groups. In these studies, other two new compounds than H2bdtc whose activity is known, were considered promising, H2bt and H2bmt, having superior activity, CC50try values 9.91 and 6.85 µM, respectively, compared with benznidazole used as reference (CC50try = 10.6 µM). The compounds also show selective with CC50> 100 µM for J774 macrophage cells. In the complexation studies with GaIII using H2bdtc it is possible to obtain two new complex, varying the reaction conditions, being a mononuclear, [Ga(bdtc)(Hbdtc)]·CH3OH, and other dinuclear [Ga2(bdtc)2(?-OCH3)2]·CH2Cl2, which were characterized both in solution and in solid state, having their structures determined by single crystals X-ray diffraction. Both having GaIII pentacoordenate, with distortion of coordination geometry between trigonal bipyramidal and square pyramidal. When the ligand bdtc2- coordinated dianionic the form is O,N,S-tridentate, unlike the form S,N-bidentate was observed for the DTC when coordinated monoanionic as bdtc1-.

Submitted by Erika Demachki (erikademachki@gmail.com) on 2017-03-16T21:37:33Z No. of bitstreams: 2 Dissertação - Soraia Santana de Moura - 2012.pdf: 3848911 bytes, checksum: 6c2c1f811c32328fc8cdb22d9edaf90a (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2017-03-20T13:38:54Z (GMT) No. of bitstreams: 2 Dissertação - Soraia Santana de Moura - 2012.pdf: 3848911 bytes, checksum: 6c2c1f811c32328fc8cdb22d9edaf90a (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) / Made available in DSpace on 2017-03-20T13:38:54Z (GMT). No. of bitstreams: 2 Dissertação - Soraia Santana de Moura - 2012.pdf: 3848911 bytes, checksum: 6c2c1f811c32328fc8cdb22d9edaf90a (MD5) license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Previous issue date: 2012-11-28 / Fundação de Apoio à Pesquisa - FUNAPE / Conselho Nacional de Pesquisa e Desenvolvimento Científico e Tecnológico - CNPq / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES / Financiadora de Estudos e Projetos- Finep / Cardiovascular diseases are among the diseases of higher mortality rates in Brazil and worldwide . In contrast, it is reducing deaths of cardiovascular diseases due, in large part, to the production of drugs that can control their risk factors, but the wide reporting of side effects and contraindications persist and interfere negatively in the context of mortality these diseases. In this point, it is necessary to develop new drugs more effective and safer. The process of development of new drug requires numerous preclinical studies that generate information regarding safety profile in vivo determinants for making the decision to start clinical trials. Although it is a conventional practice, the use of animals in scientific research should happen consciously, always considering the ethical issues of animal experimentation. In this study, we investigated the basal cytotoxicity against 3T3 cells of seven pyrazole compounds (LQFM011, LQFM012, LQFM020, LQFM021, LQFM022, and LQFM023 LQFM024) and classified then in GHS system. Whereas the compound LQFM021 proved to be the most effective in the tests performed in parallel pharmacodynamic study, we investigated whether acute oral toxicity, subacute and mutagenicity of this compound. The results showed that the compounds have low cytotoxicity profile in basal cell line (3T3). The estimated LD50 values for compounds LQFM011, LQFM012, LQFM020, LQFM021, LQFM022, and LQFM023 LQFM024 were 548, 551, 568, 533, 457, 482, 565 mg / kg, respectively. The compounds LQFM020, LQFM023 LQFM024 were classified in category 5 GHS system and LQFM021 was classified in category 4. The subacute toxicological research for 28 days LQFM021 the compound showed that this compound did not affect the metabolic, hematological and biochemical animal parameters in any of the doses of exposure However, the histopathology indicated hepatotoxic and nephrotoxic potential of this compound and interference in the process of hematopoiesis, but did not indicate mutagenic potential. . Given the above, we conside / As doenças cardiovasculares estão entre as doenças de maior letalidade no Brasil e no mundo. Em contrapartida, vê-se um quadro redução das mortes atribuídas às enfermidades cardiovasculares devido, em grande parte, à produção de medicamentos capazes de controlar seus fatores de risco, porém, o vasto relato de efeitos colaterais e contraindicações persistem e interferem negativamente no quadro de morbimortalidade dessas doenças. Neste sentindo, é imprescindível buscar novos fármacos mais efetivos e seguros. O processo de desenvolvimento de um novo fármaco exige numerosos estudos pré-clínicos que geram informações quanto ao seu perfil de segurança in vivo, determinantes para a tomada de decisão de se iniciar os estudos clínicos. Embora seja uma prática convencional, o uso de animais em pesquisas científicas deve ocorrer de forma consciente, considerando sempre as questões éticas de experimentação animal. Neste trabalho, investigou-se a citotoxicidade basal frente as células 3T3 de sete compostos pirazolínicos (LQFM011, LQFM012, LQFM020, LQFM021, LQFM022, LQFM023 e LQFM024) e suas classificações no sistema GHS. Considerando que o composto LQFM021 demonstrou ser o mais eficaz nos ensaios realizados em paralelo de farmacodinâmica, investigou-se toxicidade oral aguda, subaguda e mutagenicidade do composto. Os resultados mostraram que os compostos possuem perfil de baixa citotoxicidade em linhagem basal (3T3). Os valores de DL50 estimados para os compostos LQFM011, LQFM012, LQFM020, LQFM021, LQFM022, LQFM023 e LQFM024 foram 548, 551, 568, 533, 457, 482, 565 mg/kg, respectivamente. Os compostos LQFM020, LQFM023 e LQFM024 foram classificadas na categoria 5 do sistema GHS e o composto LQFM021 foi classificado na categoria 4. A investigação toxicológica subaguda por 28 dias do composto LQFM021 mostrou que este composto não interferiu nos parâmetros metabólico, hematológico e bioquímico dos animais em nenhuma das doses de exposição. No entanto, o estudo histopatológico indicou potencial nefrotóxico e hepatotóxico deste composto e interferência sobre o processo de hematopoiese, entretanto, não apresentou potencial mutagênico. Diante do exposto, consideramos que o composto LQFM021 apresenta um baixo perfil de toxicidade e os estudos de continuidade devem ser encorajados.